Cas:26299-14-9 pcc manufacturer & supplier

We serve Chemical Name:pcc CAS:26299-14-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

pcc

Chemical Name:pcc
CAS.NO:26299-14-9
Synonyms:Pyridinium chloro(oxido)dioxochromium;Corey’s reagent;PyridiniumChlirochromate;piridinium dichromate;pyridinium dichromate;Corey Schmidt reagent;T6NJ &&ClCrO3- Complex;Urine Luck;PYRIDINIUMCHLCHROMAT S;MFCD00013106;Pyridinium chlorochromate (PCC);PyridiuM ChloroforMate;PyridinumChlorochromate;Pyridinum chlorochromate;PCC;EINECS 247-595-5;Pyridinium chlorochr;pyridinium;dipyridinium dichromate;pyridium dichromate;pyridinum dichromate;Pyridinechloro-chromate;Pyridinium chlorochromate
Molecular Formula:C5H6ClCrNO3
Molecular Weight:215.555
HS Code:

Physical and Chemical Properties:
Melting point:205-208 °C(lit.)
Boiling point:115.3ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:67.26000
Exact Mass:214.944138
LogP:1.35670

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1479 5.1/PG 2
Packing Group:III


Contact us for information like Pyridinium chloro(oxido)dioxochromium chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridinium chlorochromate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,T6NJ &amp Use and application,pyridinium technical grade,usp/ep/jp grade.


Related News: ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. pcc manufacturer The agency said it was not yet ready to authorize Emergent BioSolutions Inc’s (EBS.N) plant for manufacturing the J&J vaccine. pcc supplier DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. pcc vendor Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant. pcc factory After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.